The Inhaled Nitric Oxide Market in trends by increasing neonatal applications

The Inhaled Nitric Oxide Market in trends by increasing neonatal applications

Inhaled nitric oxide (iNO) is a vasodilator used in neonatal care and intensive care units (ICUs) to treat hypoxic respiratory failure associated with pulmonary hypertension. It helps reduce pulmonary artery pressure and improves oxygenation in critically ill newborns with persistent pulmonary hypertension of the newborn (PPHN). The increasing premature and low birth weight babies globally have fueled the demand for inhaled nitric oxide for treating related complications.

The Global Inhaled Nitric Oxide Market is estimated to be valued at US$ 1.22 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2031. Key Takeaways

Key players operating in the Inhaled Nitric Oxide Market are Mallinckrodt plc, Linde PLC, Nippon Sanso Holdings Corporation, SOL Group, Air Liquide S.A., Air Water Inc., Chemix Specialty Gases and Equipment, Vero Biotech LLC, Sichuan Salman Chemical Products Co., Ltd., Chengdu Taiyu Industrial Gases Co., Ltd., Bellerophon Therapeutics Inc., Merck KGaA, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Messer Group, Nu-Med Plus Inc., Beyond Air Inc., Praxair Technology Inc., Getinge Group, and Circassia Pharmaceuticals.

The growing prevalence of preterm births globally has increased the demand for inhaled nitric oxide in the treatment of pulmonary hypertension in preterm infants, driving the of the Inhaled Nitric Oxide Market size witnessing expansion in emerging countries due to growing healthcare budgets and the increasing focus on developing neonatal care infrastructure. Key players are also focusing on partnerships and collaborations with hospitals in developing nations to boost access to inhaled nitric oxide therapies. Market Key Trends The increasing research on innovative modes of nitric oxide delivery is a key trend in the inhaled nitric oxide market. Companies are developing nitric oxide delivery technologies that can enable targeted and sustained delivery of nitric oxide to the lungs. This helps reduce side effects and maximize therapeutic benefits. Researchers are also working on developing “pulsed” delivery of nitric oxide that involves intermittent bursts of the gas, as opposed to continuous delivery. This approach has shown promise in reducing the amount of inhaled nitric oxide needed while still achieving the desired clinical effects. Such innovations are expected to drive market growth over the forecast period by improving treatment outcomes and expanding applications of inhaled nitric oxide.

Porter's Analysis Threat of new entrants: Low capital requirements and difficulty differentiating products limit threat.

Bargaining power of buyers: Large healthcare facilities can negotiate lower prices but overall demand is inelastic.

Bargaining power of suppliers:

The Inhaled Nitric Oxide Market challenges and opportunities include the specialized knowledge and equipment required to produce nitric oxide, which gives suppliers some leverage over pricing.

Threat of new substitutes: Limited substitutes exist for the therapeutic applications of inhaled nitric oxide.

Competitive rivalry: Competition exists between large manufacturers but differentiated products and applications limit direct competition. Geographical Regions Over 50% of the global inhaled nitric oxide market value is concentrated in North America due to the high prevalence of preterm births and supportive reimbursement structures in the US and Canada. The Asia Pacific region excluding Japan is expected to see the fastest growth in the inhaled nitric oxide market over the forecast period driven by rising standards of living, increasing healthcare investments, and growing incidence of preterm births and neonatal pulmonary hypertension in highly populated nations like India and China.

About Author: Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)